The gold nanotheranostic-mediated targeted NIR-II PTT also significantly inhibited tumor growth and triggered a strong immune response in combination with the anti-PD-L1 antibody to kill the distant breast tumors and metastatic 4T1 cells throughout the whole body in vivo. This evidence concerns the gene CD274 and neoplasm.